DCO
NYSE Ducommun Incorporated$171.60 ↑ +2.56 (+1.51%) Trading Up from the previous close of $169.04, $0.28 below the day’s high of $171.88
- YTD change
- +80.38%
- vs 20-day SMA
- +1.74%
- vs 200-day SMA
- +18.26%
Price ranges
Price & Performance
+51.94 (+44.36%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 18.4% away from all-time highs of $210.39
- DCO is up 80% since the beginning of the year
- DCO is up 84% over the past 12 months
- DCO is down 3% over the past 1 month
- 6% of all DCO investors are betting against DCO
- Number of investors short DCO has gone up 5% versus last month
DCO reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +80.9%.
- Previous minute
- +$0.37
- Last hour
- +$2.56
- Last 5 days
- +2.09%
- vs 8-day SMA
- +1.27%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Ducommun, Inc. engages in the provision of engineering and manufacturing services to the aerospace, defense, industrial, and medical industries. The firm's products include commercial, military fixed-wing, military and commercial rotary-wing aircraft, human machine interface, RF products, and motors and resolvers. It operates through the Electronic Systems and Structural Systems segments. The Electronic Systems segment offers electronic and electromechanical products used in worldwide technology-driven markets. The Structural Systems segment designs, engineers and manufactures contoured aero structure components, assemblies and supplies composite and metal bonded structures. The company was founded by Charles Louis Ducommun in 1849 and is headquartered in Costa Mesa, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.